Sahar Kassem

1.1k total citations
16 papers, 723 citations indexed

About

Sahar Kassem is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Sahar Kassem has authored 16 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Sahar Kassem's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Immune Response and Inflammation (3 papers). Sahar Kassem is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Immune Response and Inflammation (3 papers). Sahar Kassem collaborates with scholars based in France, Australia and United States. Sahar Kassem's co-authors include Abdelhadi Saoudi, Ludovic Martinet, Hervé Avet‐Loiseau, Camille Guillerey, Mark J. Smyth, Geoffrey R. Hill, Kyohei Nakamura, I Bernard, Guillaume Gaud and Mehdi Benamar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Sahar Kassem

16 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sahar Kassem France 11 390 318 271 157 48 16 723
Cristina Teixeira de Matos Sweden 8 724 1.9× 237 0.7× 244 0.9× 66 0.4× 27 0.6× 8 954
Adam Cisterne Australia 9 151 0.4× 137 0.4× 225 0.8× 233 1.5× 20 0.4× 14 571
Daniela Werth Germany 9 338 0.9× 221 0.7× 246 0.9× 63 0.4× 34 0.7× 12 659
Andrea Arruda Canada 10 255 0.7× 163 0.5× 188 0.7× 159 1.0× 23 0.5× 39 566
Francesco Boccellato Germany 12 183 0.5× 219 0.7× 263 1.0× 21 0.1× 71 1.5× 22 665
Antony Symons United States 11 613 1.6× 154 0.5× 323 1.2× 34 0.2× 34 0.7× 16 891
Laurence Goffin Switzerland 15 330 0.8× 96 0.3× 261 1.0× 51 0.3× 65 1.4× 26 723
Elaine Y. Chung United States 9 347 0.9× 136 0.4× 187 0.7× 35 0.2× 59 1.2× 15 616
M. E. Christine Lutsiak United States 10 844 2.2× 486 1.5× 260 1.0× 48 0.3× 36 0.8× 12 1.1k
Takeshi Otani Japan 15 411 1.1× 180 0.6× 316 1.2× 58 0.4× 33 0.7× 48 889

Countries citing papers authored by Sahar Kassem

Since Specialization
Citations

This map shows the geographic impact of Sahar Kassem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sahar Kassem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sahar Kassem more than expected).

Fields of papers citing papers by Sahar Kassem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sahar Kassem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sahar Kassem. The network helps show where Sahar Kassem may publish in the future.

Co-authorship network of co-authors of Sahar Kassem

This figure shows the co-authorship network connecting the top 25 collaborators of Sahar Kassem. A scholar is included among the top collaborators of Sahar Kassem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sahar Kassem. Sahar Kassem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kassem, Sahar, Nizar El-Murr, Nadège Carrié, et al.. (2022). SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma. Blood. 139(8). 1160–1176. 17 indexed citations
2.
3.
Ronin, Émilie, Maryam Khosravi, Sylvie Grégoire, et al.. (2021). Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2–expressing Treg cells. Proceedings of the National Academy of Sciences. 118(13). 37 indexed citations
4.
5.
Virone-Oddos, Angéla, Sahar Kassem, Alain Fournier, et al.. (2020). Abstract 2266: SAR442085, a next generation anti-CD38 antibody with enhanced antibody-dependent cellular cytotoxicity (ADCC) against multiple myeloma. Cancer Research. 80(16_Supplement). 2266–2266. 4 indexed citations
6.
Gaud, Guillaume, Romain Roncagalli, Karima Chaoui, et al.. (2018). The costimulatory molecule CD226 signals through VAV1 to amplify TCR signals and promote IL-17 production by CD4 + T cells. Science Signaling. 11(538). 33 indexed citations
7.
Nakamura, Kyohei, Sahar Kassem, Alice Cleynen, et al.. (2018). Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment. Cancer Cell. 33(4). 634–648.e5. 167 indexed citations
8.
Bernard, I, Sahar Kassem, Mehdi Benamar, et al.. (2018). A Natural Variant of the Signaling Molecule Vav1 Enhances Susceptibility to Myasthenia Gravis and Influences the T Cell Receptor Repertoire. Frontiers in Immunology. 9. 2399–2399. 7 indexed citations
9.
Guillerey, Camille, Heidi Harjunpää, Nadège Carrié, et al.. (2018). TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma. Blood. 132(16). 1689–1694. 222 indexed citations
10.
11.
Kassem, Sahar, I Bernard, Mehdi Benamar, et al.. (2016). A Natural Variant of the T Cell Receptor-Signaling Molecule Vav1 Reduces Both Effector T Cell Functions and Susceptibility to Neuroinflammation. PLoS Genetics. 12(7). e1006185–e1006185. 10 indexed citations
12.
Gaud, Guillaume, I Bernard, Sahar Kassem, et al.. (2015). An Epistatic Interaction between Themis1 and Vav1 Modulates Regulatory T Cell Function and Inflammatory Bowel Disease Development. The Journal of Immunology. 195(4). 1608–1616. 12 indexed citations
13.
Saoudi, Abdelhadi, Sahar Kassem, Anne S. Dejean, & Guillaume Gaud. (2014). Rho-GTPases as key regulators of T lymphocyte biology. Small GTPases. 5(4). e983862–e983862. 54 indexed citations
14.
Smirnova, Natalia, Stéphanie Gayral, Gervaise Loirand, et al.. (2014). Targeting PI3Kγ activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response. The Journal of Experimental Medicine. 211(9). 1779–1792. 26 indexed citations
15.
Faris, R, et al.. (1986). Indigenously acquired human visceral leishmaniasis in Al Agamy (Alexandria Governorate) Egypt.. PubMed. 66(4). 325–9. 2 indexed citations
16.
Kassem, Sahar, et al.. (1983). A preliminary report on two cases of visceral leishmaniasis in Egypt. Transactions of the Royal Society of Tropical Medicine and Hygiene. 77(3). 334–335. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Teixeira de Matos Breakdown of academic impact, for papers by Adam Cisterne Breakdown of academic impact, for papers by Daniela Werth Breakdown of academic impact, for papers by Andrea Arruda Breakdown of academic impact, for papers by Francesco Boccellato Breakdown of academic impact, for papers by Antony Symons Breakdown of academic impact, for papers by Laurence Goffin Breakdown of academic impact, for papers by Elaine Y. Chung Breakdown of academic impact, for papers by M. E. Christine Lutsiak Breakdown of academic impact, for papers by Takeshi Otani
Rankless by CCL
2026